Point72 Hong Kong’s Atara Biotherapeutics ATRA Stock Holding History

Point72 Hong Kong’s Portfolio ATRA Stock Details ATRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-257	Closed	-$24K	–	186
2022 Q3	$24K	Buy	+257	New	+$28.9K	﹤0.01%	1586
2022 Q2	–	Sell	-289	Closed	-$67K	–	1902
2022 Q1	$67K	Buy	289 +224	+345%	+$71.3K	﹤0.01%	1262
2021 Q4	$26K	Sell	65 -249	-79%	-$105K	﹤0.01%	1497
2021 Q3	$140K	Buy	314 +289	+1,156%	+$104K	﹤0.01%	1261
2021 Q2	$10K	Sell	25 -44	-64%	-$15.7K	﹤0.01%	1738
2021 Q1	$25K	Sell	69 -55	-44%	-$24.3K	﹤0.01%	1425
2020 Q4	$61K	Buy	+124	New	+$57.2K	﹤0.01%	1171
2020 Q3	–	Sell	-213	Closed	-$78K	–	1183
2020 Q2	$78K	Buy	+213	New	+$53.8K	0.01%	676
2019 Q3	–	Sell	-29	Closed	-$15K	–	998
2019 Q2	$15K	Buy	+29	New	+$20.5K	﹤0.01%	816

Other funds holding ATRA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return